Viridien
Short position disclosed on October 21, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| September 12, 2016 | Whitebox Advisors LLC | 0.63% | February 28, 2018 | |
| September 9, 2016 | Oxford Asset Management LLP | 0.61% | December 8, 2016 | |
| September 8, 2016 | Oxford Asset Management LLP | 0.59% | December 8, 2016 | |
| September 5, 2016 | GSA Capital Partners LLP | 0.91% | September 19, 2017 | |
| August 31, 2016 | Oceanic Hedge Fund | 0.47% | September 2, 2016 | |
| August 29, 2016 | Oceanic Opportunities Master Fund, L.P. | 1.28% | August 15, 2017 | |
| August 29, 2016 | Oceanic Hedge Fund | 0.51% | September 2, 2016 | |
| August 26, 2016 | Oceanic Opportunities Master Fund, L.P. | 1.15% | August 15, 2017 | |
| August 24, 2016 | Oceanic Opportunities Master Fund, L.P. | 1.07% | August 15, 2017 | |
| August 23, 2016 | Oceanic Opportunities Master Fund, L.P. | 0.79% | August 15, 2017 | |
| August 23, 2016 | Citadel Advisors II LLC | 0.49% | August 25, 2016 | |
| August 18, 2016 | Citadel Advisors II LLC | 0.57% | August 25, 2016 | |
| August 17, 2016 | Oxford Asset Management LLP | 0.61% | December 8, 2016 | |
| August 17, 2016 | Citadel Advisors II LLC | 0.60% | August 25, 2016 | |
| August 16, 2016 | Citadel Advisors II LLC | 0.53% | August 25, 2016 | |
| August 8, 2016 | TT International | 0.53% | October 26, 2016 | |
| August 3, 2016 | Whitebox Advisors LLC | 0.56% | February 28, 2018 | |
| July 26, 2016 | GSA Capital Partners LLP | 0.89% | September 19, 2017 | |
| July 25, 2016 | GSA Capital Partners LLP | 0.90% | September 19, 2017 | |
| July 22, 2016 | GSA Capital Partners LLP | 0.89% | September 19, 2017 | |
| July 22, 2016 | Oxford Asset Management LLP | 0.57% | December 8, 2016 | |
| July 18, 2016 | GSA Capital Partners LLP | 0.99% | September 19, 2017 | |
| July 15, 2016 | UBS Asset Management (UK) Ltd | 8.11% | October 25, 2017 | |
| July 15, 2016 | GSA Capital Partners LLP | 1.05% | September 19, 2017 | |
| July 14, 2016 | GSA Capital Partners LLP | 1.10% | September 19, 2017 | |
| July 13, 2016 | UBS Asset Management (UK) Ltd | 8.02% | October 25, 2017 | |
| July 13, 2016 | GSA Capital Partners LLP | 1.09% | September 19, 2017 | |
| July 6, 2016 | GSA Capital Partners LLP | 1.10% | September 19, 2017 | |
| July 5, 2016 | GSA Capital Partners LLP | 1.09% | September 19, 2017 | |
| June 28, 2016 | GSA Capital Partners LLP | 1.11% | September 19, 2017 | |
| June 24, 2016 | Oxford Asset Management LLP | 0.63% | December 8, 2016 | |
| June 22, 2016 | UBS Asset Management (UK) Ltd | 7.82% | October 25, 2017 | |
| June 17, 2016 | GSA Capital Partners LLP | 1.01% | September 19, 2017 | |
| June 14, 2016 | Oxford Asset Management LLP | 0.52% | December 8, 2016 | |
| June 6, 2016 | GSA Capital Partners LLP | 0.90% | September 19, 2017 | |
| June 3, 2016 | UBS Asset Management (UK) Ltd | 7.76% | October 25, 2017 | |
| June 2, 2016 | UBS Asset Management (UK) Ltd | 7.53% | October 25, 2017 | |
| June 1, 2016 | UBS Asset Management (UK) Ltd | 7.28% | October 25, 2017 | |
| May 26, 2016 | GSA Capital Partners LLP | 0.81% | September 19, 2017 | |
| May 18, 2016 | GSA Capital Partners LLP | 0.70% | September 19, 2017 | |
| May 17, 2016 | UBS Asset Management (UK) Ltd | 7.12% | October 25, 2017 | |
| May 16, 2016 | UBS Asset Management (UK) Ltd | 6.71% | October 25, 2017 | |
| May 16, 2016 | Makuria Investment Management (UK) LLP | 0.00% | May 18, 2016 | |
| May 11, 2016 | Whitebox Advisors LLC | 0.68% | February 28, 2018 | |
| May 11, 2016 | GSA Capital Partners LLP | 0.61% | September 19, 2017 | |
| May 9, 2016 | GSA Capital Partners LLP | 0.50% | September 19, 2017 | |
| May 4, 2016 | UBS Asset Management (UK) Ltd | 6.34% | October 25, 2017 | |
| April 22, 2016 | Makuria Investment Management (UK) LLP | 0.56% | May 18, 2016 | |
| April 21, 2016 | UBS Asset Management (UK) Ltd | 6.27% | October 25, 2017 | |
| April 21, 2016 | Makuria Investment Management (UK) LLP | 0.67% | May 18, 2016 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=40